Clinical trials
Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
101 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 12 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 33 |
| Completed | 25 |
| Recruiting | 23 |
| Active, not recruiting | 10 |
| Not yet recruiting | 6 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 9 |
| Peking University People's Hospital | 8 |
| Pfizer | 6 |
| First Hospital of Shijiazhuang City | 3 |
| Fudan University | 3 |
| Jinling Hospital, China | 3 |
| West China Hospital | 3 |
| Bayer | 2 |
| Guangzhou Medical University | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 101 |
| Carcinoma, Non-Small-Cell Lung | 30 |
| Lung Neoplasms | 23 |
| Neoplasms | 18 |
| Adenocarcinoma | 11 |
| Carcinoma, Hepatocellular | 10 |
| Neoplasms by Site | 9 |
| Neoplasm Metastasis | 8 |
| Neoplasms by Histologic Type | 8 |
| Digestive System Neoplasms | 7 |
Trials
Showing 26 to 50 of 101. Each trial links to its page on Pharma Observatory.
1 more trial matches. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.